Zura Bio Limited(ZURA)

Biotechnology · Henderson, NV

$3.96+0.03 (+0.76%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T21:29:39.078Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:29:39.078Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -92,689,000
Quote market capitalization: 376,190,932
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 205,134,000

FMP input reference: 48a9c173a70739b1093346a936f860d9c8f80d7eeb2565194c7199b3c596865c

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ZURA EBITDA Yield Metrics

EBITDA YIELD

N/A

ZURA Competitors' EBITDA Yield

ZURA

Zura Bio Limited

Current

Market Cap

$376.19M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CGC

Canopy Growth Corporation

vs ZURA

Market Cap

$376.01M

EBITDA Yield

N/A

TTM Avg

0.15%

3Y Avg

0.15%

5Y Avg

0.15%

KYTX

Kyverna Therapeutics, Inc.

vs ZURA

Market Cap

$374.50M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OFIX

Orthofix Medical Inc.

vs ZURA

Market Cap

$380.37M

EBITDA Yield

23.41%

TTM Avg

11.41%

3Y Avg

9.82%

5Y Avg

7.66%

ARCT

Arcturus Therapeutics Holdings Inc.

vs ZURA

Market Cap

$369.50M

EBITDA Yield

N/A

TTM Avg

12.83%

3Y Avg

12.83%

5Y Avg

12.83%

RGNX

REGENXBIO Inc.

vs ZURA

Market Cap

$385.15M

EBITDA Yield

N/A

TTM Avg

13.79%

3Y Avg

13.79%

5Y Avg

8.78%

IRD

Opus Genetics, Inc.

vs ZURA

Market Cap

$361.64M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FENC

Fennec Pharmaceuticals Inc.

vs ZURA

Market Cap

$359.53M

EBITDA Yield

N/A

TTM Avg

3.23%

3Y Avg

3.23%

5Y Avg

3.23%

Shoulder Innovations, Inc.

vs ZURA

Market Cap

$396.93M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARTV

Artiva Biotherapeutics, Inc.

vs ZURA

Market Cap

$355.43M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Zura Bio Limited (ZURA)	$376.19M	N/A	N/A	N/A	N/A
Canopy Growth Corporation (CGC)vs ›	$376.01M	N/A	0.15%	0.15%	0.15%
Kyverna Therapeutics, Inc. (KYTX)vs ›	$374.50M	N/A	N/A	N/A	N/A
Orthofix Medical Inc. (OFIX)vs ›	$380.37M	23.41%	11.41%	9.82%	7.66%
Arcturus Therapeutics Holdings Inc. (ARCT)vs ›	$369.50M	N/A	12.83%	12.83%	12.83%
REGENXBIO Inc. (RGNX)vs ›	$385.15M	N/A	13.79%	13.79%	8.78%
Opus Genetics, Inc. (IRD)vs ›	$361.64M	N/A	N/A	N/A	N/A
Fennec Pharmaceuticals Inc. (FENC)vs ›	$359.53M	N/A	3.23%	3.23%	3.23%
Shoulder Innovations, Inc. (SI)vs ›	$396.93M	N/A	N/A	N/A	N/A
Artiva Biotherapeutics, Inc. (ARTV)vs ›	$355.43M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

ZURA EBITDA Yield Metrics

ZURA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics